花旗发表研究报告对中国人寿开展为期30日的负面催化剂观察期表示担忧公司2025年上半年盈利增长可能逊预期主要由于利率下行

智通财经
Aug 08
花旗发表研究报告对中国人寿开展为期30日的负面催化剂观察期表示担忧公司2025年上半年盈利增长可能逊预期主要由于利率下行拖累保险服务费用及净投资收益表现相信将低于市场普遍预期的按年增长20%。花旗目前预测国寿上半年净利润按年增长5%至403亿元增速较首季大幅放缓。花旗维持国寿的“买入”评级目标价26.1港元仍看好其品牌优势及长期增长潜力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10